Shadia Nakalema

Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks

Kimberly K. Scarsi, Kristin M. Darin, Shadia Nakalema et al. · Clinical Infectious Diseases · 2015 · 87 citations · Full text

Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother–infant pairs

Catriona Waitt, Adeniyi Olagunju, Shadia Nakalema et al. · Journal of Antimicrobial Chemotherapy · 2017 · 46 citations · Full text

Efavirenz decreases etonogestrel exposure

Catherine A. Chappell, Mohammed Lamorde, Shadia Nakalema et al. · AIDS · 2017 · 43 citations

Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics of Efavirenz 400 mg Once Daily During Pregnancy and Post-Partum

Mohammed Lamorde, Xinzhu Wang, Megan Neary et al. · Clinical Infectious Diseases · 2018 · 26 citations · Full text

Efavirenz‐ but not nevirapine‐based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub‐dermal contraceptive implant

Kimberly K. Scarsi, Mohammed Lamorde, Kristin M. Darin et al. · Journal of the International AIDS Society · 2014 · 24 citations · Full text